Robert Carlson

Clinical Focus

• Cancer> Breast Cancer
• Breast Cancer - Medical Oncology
• Oncology (Cancer)
• Medical Oncology

Professional Education

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Current Research Interests

Clinical investigations in breast cancer include institutional and NSABP studies of chemoprevention, adjuvant therapy, psychosocial interventions, treatment of metastatic disease, methods of decreasing anthracycline cardiotoxicity, and modulation of multidrug resistance. Research in meta-analysis includes the performance of meta-analysis in a wide variety of settings in cancer treatment by the international Meta-Analysis Group in Cancer.

Computer science research efforts focus on computer-based systems for patient care. These include: the development of expert systems to assist in the care of patients with cancer (ONCOCIN) or AIDS (T-Helper); the development of computer-based systems using speech and pen-based input for medical records to access sources of medical knowledge; the design of three-dimensional methods of performing and representing literature searches; and the development of standards for implementing of medical computer-based systems; the development of smart agents and medical ontologies.

Clinical Trials

• A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer Recruiting
• Development of Vitamin D as a Therapy for Breast Cancer - Phase II Recruiting
• Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption Recruiting
• Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer Recruiting
• B-Receptor Signaling in Cardiomyopathy Recruiting

Publications

• Rational Surveillance Programs for Early Stage Breast Cancer Patients After Primary Treatment. Mollick JA, Carlson RW. Breast Dis. 2009: 21 47-54
• First-line chemotherapy for metastatic breast cancer. Telli ML, Carlson RW. Clin Breast Cancer. 2009: 9 Suppl 2 S66-72
• Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer. Svahn TH, Niland JC, Carlson RW, Hughes ME, Ottesen RA, Theriault RL, Edge SB, Schott AF, Bookman MA, Weeks JC. J Natl Compr Canc Netw. 2009; 7 (2): 115-21
• The decline in breast cancer incidence: real or imaginary? Kurian AW, Clarke CA, Carlson RW. Curr Oncol Rep. 2009; 11 (1): 21-8
• Selecting high priority quality measures for breast cancer quality improvement. Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, Carlson RW, Theriault RL, Weeks JC. Med Care. 2008; 46 (8): 762-70